1 |
MAPK14
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
2 |
MAPK14
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
3 |
CSF2
| 2件: TNF signaling pathway TNF signaling pathway, Transcriptional misregulation in cancer | D11343
D11343
|
Otilimab
| 1件: 46 46 |
4 |
IL1B
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
5 |
IL1B
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis | D06635
D06635
|
Rilonacept
| 4件: 51 51, 106, 107, 266 |
6 |
IL1B
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis | D09315
D09315
|
Canakinumab
| 10件: 46 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 |
7 |
IL1B
| 5件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis | D09911
D09911
|
Gevokizumab
| 4件: 41 41, 50, 56, 269 |
8 |
IL6
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
9 |
IL6
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
10 |
IL6
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D09669
D09669
|
Siltuximab
| 2件: 28 28, 331 |
11 |
IL6
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D10080
D10080
|
Sirukumab
| 2件: 41 41, 46 |
12 |
IL6
| 6件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D12487
D12487
|
Olokizumab
| 2件: 46 46, 96 |
13 |
LTA
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TNF signaling pathway, Type I diabetes mellitus | D00742
D00742
|
Etanercept
| 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
14 |
LTA
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TNF signaling pathway, Type I diabetes mellitus | D10187
D10187
|
Pateclizumab
| 1件: 46 46 |
15 |
MAP3K5
| 1件: TNF signaling pathway TNF signaling pathway | D10988
D10988
|
Selonsertib
| 1件: 86 86 |
16 |
NFKB1
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D01146
D01146
|
Iguratimod
| 5件: 46 46, 51, 53, 271, 300 |
17 |
PIK3CA
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
18 |
PIK3CA
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
19 |
PIK3CB
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
20 |
PIK3CD
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
21 |
PIK3CD
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Yersinia infection, Viral carcinogenesis | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
22 |
MAPK11
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
23 |
MAPK11
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
24 |
MAPK13
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
25 |
MAPK13
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
26 |
MAP2K1
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
27 |
MAP2K1
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
28 |
MAP2K1
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
29 |
MAP2K1
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
30 |
MAP2K1
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
31 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00109
D00109
|
Acetylsalicylic acid
| 14件: 13 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251 |
32 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00118
D00118
|
Naproxen
| 4件: 13 13, 46, 107, 271 |
33 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00120
D00120
|
Sulindac
| 1件: 206 206 |
34 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00126
D00126
|
Ibuprofen
| 7件: 13 13, 46, 65, 107, 113, 271, 299 |
35 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00130
D00130
|
Diflunisal
| 1件: 28 28 |
36 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00132
D00132
|
Ketoprofen
| 1件: 46 46 |
37 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00141
D00141
|
Indomethacin
| 3件: 225 225, 271, 298 |
38 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00217
D00217
|
Acetaminophen
| 15件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 |
39 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00315
D00315
|
Etodolac
| 1件: 46 46 |
40 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00330
D00330
|
Flurbiprofen
| 3件: 13 13, 21, 46 |
41 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00428
D00428
|
Salsalate
| 1件: 5 5 |
42 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00567
D00567
|
Celecoxib
| 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
43 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00568
D00568
|
Rofecoxib
| 1件: 46 46 |
44 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D00969
D00969
|
Meloxicam
| 4件: 46 46, 49, 271, 296 |
45 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D01049
D01049
|
Nimesulide
| 1件: 46 46 |
46 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D01183
D01183
|
Tolfenamic acid
| 1件: 5 5 |
47 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D01545
D01545
|
Aceclofenac
| 1件: 46 46 |
48 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D02709
D02709
|
Valdecoxib
| 1件: 46 46 |
49 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D03710
D03710
|
Etoricoxib
| 2件: 46 46, 271 |
50 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D03714
D03714
|
Lumiracoxib
| 1件: 46 46 |
51 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D03716
D03716
|
Parecoxib
| 2件: 46 46, 271 |
52 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D07816
D07816
|
Diclofenac
| 5件: 13 13, 34, 46, 78, 271 |
53 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D08104
D08104
|
Ketorolac
| 2件: 70 70, 226 |
54 |
PTGS2
| 2件: VEGF signaling pathway VEGF signaling pathway, TNF signaling pathway | D08149
D08149
|
Loxoprofen
| 2件: 46 46, 271 |
55 |
RELA
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis | D12181
D12181
|
Edasalonexent
| 1件: 113 113 |
56 |
MAPK12
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
57 |
MAPK12
| 6件: VEGF signaling pathway VEGF signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
58 |
CCL2
| 3件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TNF signaling pathway, Yersinia infection | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
59 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00742
D00742
|
Etanercept
| 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
60 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00754
D00754
|
Thalidomide
| 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
61 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
62 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02597
D02597
|
Adalimumab
| 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
63 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02598
D02598
|
Infliximab
| 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
64 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D03441
D03441
|
Certolizumab pegol
| 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 |
65 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04358
D04358
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
66 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04687
D04687
|
Lenalidomide
| 8件: 16 16, 26, 28, 34, 49, 284, 300, 331 |
67 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D05393
D05393
|
Pegsunercept
| 1件: 46 46 |
68 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
69 |
TNF
| 8件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D09944
D09944
|
Ozoralizumab
| 1件: 46 46 |